During this Conference, the researcher Valentín Ceña Callejo presented line of action 5 developed at the University of Castilla-La Mancha: “Pharmacological characterization of nanoparticles”. This line is carried out in collaboration with the Singular Center for Research in Molecular Medicine and Chronic Diseases (USC) and CICbioGUNE, and is focused on the treatment of glioblastoma using nanoparticles, with an approach that seeks to integrate criteria of equity and diversity in research.
The Neurodeath Associated Unit, the result of the collaboration between the University of Castilla-La Mancha (UCLM) and the Spanish National Research Council (CSIC), has recently strengthened its research capacity with the incorporation of a
The Neurodeath Associated Unit (Spanish National Research Council / University of Castilla-La Mancha), belonging to the Institute of Molecular Nanoscience (INAMOL) of the University of Castilla-La Mancha (UCLM), has published an article in the
Juan A. Sánchez Margallo, a researcher at the Jesús Usón Minimally Invasive Surgery Center (CCMIJU) in Cáceres, recently participated in the 33rd. international congress of the European Association for Endoscopic Surgery (EAES), held in